SSC Transplant + Testicular Tissue Grafting for Male Infertility

Recruiting in Palo Alto (17 mi)

Overseen by Kyle E Orwig, PhD

Age: Any Age

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Pittsburgh

Disqualifiers: Leukemia, Lymphoma, Testicular cancer, others

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial tests two methods to help men who stored testicular tissue before harmful treatments. It aims to restore their ability to produce sperm by reintroducing essential cells into their testes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment SSC Transplant + Testicular Tissue Grafting for Male Infertility?

Research shows that spermatogonial stem cell (SSC) transplantation and testicular tissue grafting have been successful in animal models, like mice, and are being developed as fertility preservation strategies for young boys undergoing treatments that risk infertility. These methods have the potential to restore sperm production by placing SSCs back into their natural environment in the testes. ^{1 2 3 4 5}

Is SSC Transplant + Testicular Tissue Grafting safe for humans?

Research on spermatogonial stem cell (SSC) transplantation and testicular tissue grafting is ongoing, with some studies showing successful transplantation in animal models. However, the safety of these procedures in humans, especially for those with tumors, remains uncertain and is still under investigation. ^{1 2 5 6 7}

How is the SSC Transplant + Testicular Tissue Grafting treatment different from other treatments for male infertility?

This treatment is unique because it involves transplanting spermatogonial stem cells (SSCs) and grafting testicular tissue to restore fertility, which is particularly promising for male prepubertal cancer survivors. Unlike traditional treatments, it aims to reconstitute spermatogenesis (the process of sperm cell development) by using the patient's own cells, potentially offering a personalized and regenerative approach to treating infertility. ^{1 2 4 5 8}

Research Team

Kyle E Orwig, PhD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for males who have frozen their testicular tissue before undergoing treatments that could cause infertility, like chemotherapy or radiation. They must be healthy enough for anesthesia and past Tanner stage 3 of puberty. Those with a history of certain cancers or conditions affecting consent are not eligible.

Inclusion Criteria

I have my testicular tissue/cells stored for future use due to a treatment that could cause infertility.

My doctor has approved me for a stem cell transplant after finishing my primary treatment.

I am healthy enough to be put under anesthesia.

Exclusion Criteria

I have a history of leukemia, lymphoma, testicular cancer, or cancer that affected my testicles.

You have a mental or emotional condition that stops you from fully understanding the study and giving informed consent.

I am at high risk for complications if I undergo surgery.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo spermatogonial stem cell transplantation and testicular tissue grafting

3 months

Follow-up

Participants are monitored for return of spermatogenesis and surgical complications

3 months

Long-term Follow-up

Participants are monitored for cancer recurrence

5 years

Treatment Details

Interventions

• Spermatogonial Stem Cell Transplant and Testicular Tissue Grafting (Stem Cell Therapy)

Trial Overview The study tests the safety and feasibility of restoring fertility through spermatogonial stem cell transplant and testicular tissue grafting in participants who've had gonadotoxic therapy.

Participant Groups

Group I: Spermatogonial Stem Cell Transplant & Testicular Tissue Graft Experimental Treatment 1 Intervention

Stem cell transplantation Testicular tissue grafting

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Magee-Womens Hospital Pittsburgh, PA

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials

1820

Patients Recruited

16,360,000+

Findings from Research

In this study involving human spermatogonial stem cells (SSCs) transplanted into azoospermic mouse testes, both in vitro transplantation (IVT) and in vivo methods resulted in a significant increase in the number of SSCs and their successful integration into the seminiferous tubules compared to control groups after two weeks.

The expression of the PLZF protein confirmed the identity of the transplanted SSCs, and while both transplantation methods showed similar gene expression levels, the study highlights the potential of testicular tissue culture conditions to enhance SSC integration into the testis.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Successful Human Spermatogonial Stem Cells Homing in Recipient Mouse Testis after In Vitro Transplantation and Organ Culture. Mohaqiq, M., Movahedin, M., Mazaheri, Z., et al.[2022]

Spermatogonial stem cell (SSC) transplantation can effectively restore spermatogenesis in a mouse model of B cell acute lymphocytic leukemia, with significant proliferation of SSCs observed after 12 weeks.

Using immunomagnetic beads and flow cytometry for SSC purification was shown to be safe, as it did not lead to tumor cell infiltration in recipient mice, unlike the density gradient centrifugation method, suggesting a safer approach for fertility preservation in cancer patients.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Relative safety of various spermatogenic stem cell purification methods for application in spermatogenic stem cell transplantation. Tian, J., Ma, K., Pei, CB., et al.[2020]

References

1. United States pubmed.ncbi.nlm.nih.gov

Testicular cell transplantation into the human testes. [2015]

2. United States pubmed.ncbi.nlm.nih.gov

Isolation, Cryopreservation, and Transplantation of Spermatogonial Stem Cells. [2020]

3. France pubmed.ncbi.nlm.nih.gov

[Fertility preservation in boys: spermatogonial stem cell transplantation and testicular grafting]. [2013]

4. England pubmed.ncbi.nlm.nih.gov

Successful transplantation of spermatogonial stem cells into the seminiferous tubules of busulfan-treated mice. [2021]

5. Iran pubmed.ncbi.nlm.nih.gov

Successful Human Spermatogonial Stem Cells Homing in Recipient Mouse Testis after In Vitro Transplantation and Organ Culture. [2022]

6. England pubmed.ncbi.nlm.nih.gov

Relative safety of various spermatogenic stem cell purification methods for application in spermatogenic stem cell transplantation. [2020]

7. Netherlands pubmed.ncbi.nlm.nih.gov

[Cryopreservation of testicular tissue in children]. [2014]

8. Iran pubmed.ncbi.nlm.nih.gov

Propagation of human germ stem cells in long-term culture. [2021]